The trajectory of Sildenafil presents a complex case for investors in the drug sector. While initially a tremendous success, creating billions, the exclusivity lapse and the subsequent entry of generic competitors have https://gambling811675.mdkblog.com/47923633/the-little-copyright-and-pharma-a-speculative-bet